Online: | |
Visits: | |
Stories: |
Story Views | |
Now: | |
Last Hour: | |
Last 24 Hours: | |
Total: |
VentriPoint Diagnostics (CVE:VPT) said it intends to complete a non-brokered private placement of up to 6.25mln units at 32 cents per unit for total gross proceeds of up to C$2mln.
Each unit will consist of one common share of VentriPoint and one common share warrant. Each warrant will entitle the holder thereof to acquire one additional common share at a price of 50 cents per common share for a period of two years after the issuance of the warrant.
The corporation will use the proceeds of the private placement for sales and marketing and general working capital purposes.
The corporation may pay a cash finder’s fee on a portion of the proceeds of the offering and may issue to finders common shares of up to 4% of the number of units purchased by subscribers introduced to the corporation by the finder, and non-transferable finders’ warrants of up to 4% of the number of units purchased by such subscribers.
Each finder’s warrant would entitle the holder to acquire one additional common share at a price of 50 cents per common share for a period of two years after the issuance of the finder’s warrant.
Story by ProactiveInvestors